Mounjaro vs Ozempic: Which Weight Loss Injection Works Better in India?
If you have been researching weight loss injections in India, you have almost certainly come across two names – Mounjaro and Ozempic. Both are weekly injections. Both help with weight loss. And both are now available in India under medical prescription.
But they are not the same. They work differently, produce different results, and cost differently in the Indian market. This guide gives you a clear, honest comparison of Mounjaro vs Ozempic so you can walk into a doctor’s consultation already informed — and ask the right questions.
“In India, over 100 million people are currently living with diabetes, and an additional 135 million are prediabetic. Obesity is closely linked to this crisis, making effective medical weight management more important than ever.” — Indian Council of Medical Research (ICMR), 2023
What Is Mounjaro?
Mounjaro is the brand name for tirzepatide, a prescription injection developed by Eli Lilly. It was approved by India’s Central Drugs Standard Control Organisation (CDSCO) and launched in India in March 2025.
Mounjaro works on two hormones — GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This is called a dual-receptor mechanism, and it is what makes Mounjaro stand apart from other injections in this category.
It is injected once a week, under the skin, and must be taken under doctor’s supervision.
What Is Ozempic?
Ozempic is the brand name for semaglutide, a prescription injection developed by Novo Nordisk. It launched in India in December 2025.
Ozempic works on one hormone — GLP-1 only. It slows digestion, reduces appetite, and helps control blood sugar. It is also injected once a week.
Semaglutide (the active ingredient in Ozempic) is also sold under the brand name Wegovy, which is specifically approved for weight management.
How Do They Work? A Simple Explanation
Both injections mimic hormones that your gut naturally releases after eating. These hormones signal your brain that you are full, slow down digestion, and help control blood sugar.
Here is where they differ:
| Mounjaro (Tirzepatide) | Ozempic (Semaglutide) | |
|---|---|---|
| Hormones targeted | GLP-1 + GIP (dual action) | GLP-1 only |
| Appetite suppression | Stronger | Moderate |
| Injection frequency | Once a week | Once a week |
| Available in India since | March 2025 | December 2025 |
| Approved by CDSCO | Yes | Yes |
| Prescription required | Yes | Yes |
The dual-action mechanism of Mounjaro is the key reason it tends to produce stronger results. GIP works alongside GLP-1 to further reduce appetite and improve how the body processes fat.
Mounjaro vs Ozempic: Weight Loss Results
This is the question most people are asking. Let us look at what clinical studies have found.
Mounjaro Results
In the landmark SURMOUNT-1 trial published in the New England Journal of Medicine, patients on the highest dose of Mounjaro (15 mg) lost an average of 20.9% of their body weight over 72 weeks. For someone weighing 90 kg, that is approximately 18–19 kg of weight lost.
Around 50% of patients on higher doses lost 20% or more of their body weight.
Ozempic Results
In the STEP-1 trial, patients on semaglutide lost an average of 14.9% of their body weight over 68 weeks. This is still a significant and clinically meaningful result.
Head-to-Head Comparison
A real-world study published in JAMA Internal Medicine compared over 18,000 patients on both medications. The findings were clear:
| Outcome | Mounjaro | Ozempic |
|---|---|---|
| Patients losing ≥ 5% weight | 81.8% | 66.5% |
| Patients losing ≥ 10% weight | 62.1% | 37.1% |
| Patients losing ≥ 15% weight | 42.3% | 18.1% |
| Average total weight loss (12 months) | 15.3% | 8.3% |
Source: JAMA Internal Medicine, real-world comparative study
Bottom line: Mounjaro consistently produces more weight loss than Ozempic across all categories. However, Ozempic still delivers meaningful results and may suit patients who need a more affordable option.
Mounjaro vs Ozempic: Cost in India (2026)
Cost is a major factor for Indian patients, as most health insurance plans in India currently cover neither medication.
| Medication | Monthly Cost (India) |
|---|---|
| Mounjaro 2.5 mg (starting dose) | ₹20,000 per month |
| Mounjaro 5 mg | ₹24,000 per month |
| Mounjaro 15 mg (highest dose) | ₹35,000 per month |
| Ozempic 0.5 mg | ₹8,800 per month |
| Ozempic 1 mg | ₹11,175 per month |
Prices are approximate and subject to change. Consultation fees are separate.
Mounjaro is priced higher, but its stronger results mean many patients achieve their goals in fewer months — which can balance out the total cost of treatment.
Side Effects: What to Expect
Both injections share a similar side effect profile because they both work on the GLP-1 pathway. Most side effects are mild and temporary, and they usually settle after the first few weeks as your body adjusts.
Common Side Effects of Both
- Nausea (most common, especially in the first 4 weeks)
- Mild diarrhoea or constipation
- Reduced appetite
- Mild stomach discomfort
Differences in Side Effects
- Mounjaro tends to cause slightly more diarrhoea in some patients
- Ozempic tends to cause more nausea in the early weeks
Both carry a small risk of more serious effects, such as pancreatitis, which is why doctor supervision is non-negotiable
“These medications should only be prescribed and monitored by qualified physicians. Self-medicating with weight loss injections without proper screening is unsafe and can lead to serious health complications.” — Central Drugs Standard Control Organisation (CDSCO), Government of India
Who Should Not Take These Injections
Neither medication is suitable if you have:
- A personal or family history of medullary thyroid cancer
- Multiple endocrine neoplasia type 2 (MEN2)
- Severe gastrointestinal conditions
- Are you pregnant or breastfeeding
Always disclose your full medical history to your doctor before starting either treatment.
Mounjaro vs Ozempic: Which One Is Right for You?

There is no single correct answer. The right choice depends on your specific health situation. Here is a simple guide:
Consider Mounjaro if:
- You want maximum weight loss results
- You have both obesity and type 2 diabetes
- You are comfortable with a higher monthly cost
- You want faster visible results (noticeable from month 2 in many patients)
Consider Ozempic if:
- Budget is a key consideration
- You have cardiovascular disease (Ozempic has specific heart-protective approvals)
- You are starting with a lower dose and want to see how your body responds
- You prefer a medication with a longer track record globally
In both cases, you need:
- A valid prescription from a qualified doctor
- Regular monitoring and follow-up consultations
- A structured diet and lifestyle plan alongside the medication
Why Doctor Supervision Matters in India
Both Mounjaro and Ozempic are Schedule H prescription drugs in India. They cannot legally be purchased without a doctor’s prescription, and for good reason.
Proper supervision includes:
- Medical screening before starting — checking thyroid, liver, kidney, and heart health
- Dose titration — starting low and increasing gradually to reduce side effects
- Regular check-ins — monitoring weight loss, blood sugar, and overall health
- Diet guidance — medication works significantly better alongside a structured nutrition plan
- Post-treatment planning — addressing weight maintenance after completing the programme
At Vivo Body & Skin Clinic, our doctor-supervised Mounjaro programme includes an initial medical consultation, personalised dosing, and ongoing monitoring throughout your treatment journey. Book a free consultation here.
Conclusion
Both Mounjaro and Ozempic represent a genuine advancement in medical weight loss — and both are now accessible in India under doctor supervision.
If weight loss is your primary goal and budget allows, Mounjaro’s dual-action mechanism delivers stronger, faster results based on current clinical evidence. If affordability is a priority or you have specific cardiovascular concerns, Ozempic remains a highly effective option.
What both injections have in common is this: they work best under proper medical supervision, alongside a healthy diet and an active lifestyle. They are not shortcuts — they are medical tools that, when used correctly, can produce life-changing results.
If you are considering either treatment, the right first step is a thorough medical consultation. Ready to take that step? Book a free consultation at Vivo Body & Skin Clinic today.
Frequently Asked Questions
Based on clinical studies, Mounjaro produces around 20.9% average weight loss compared to 14.9% with Ozempic. For most patients seeking maximum results, Mounjaro has the stronger evidence. However, the right choice depends on your health profile and budget.
No. Both are Schedule H prescription drugs in India, approved by CDSCO. You must consult a qualified doctor and obtain a valid prescription before purchasing.
Most patients notice reduced appetite within the first 2–4 weeks. Visible weight loss typically begins around weeks 4–8, with full results seen over 6–12 months.
In India, both medications are primarily approved for type 2 diabetes management. They may be used for weight loss under medical supervision, but this must be assessed by a doctor based on your BMI and health conditions.
Weight regain is common after stopping without lifestyle changes in place. Both medications work best as part of a long-term plan that includes diet and exercise. Always discuss a plan for stopping with your doctor.
Yes. Many patients combine Mounjaro (for overall weight reduction) with non-surgical body contouring treatments like fat freezing (cryolipolysis) for targeted fat reduction in specific areas. Your doctor will advise what is suitable for your goals.
Clinical trials show average weight loss of 15% to 21% of body weight over 12–18 months with the highest doses. Individual results depend on starting weight, diet, lifestyle, and consistency of treatment.
Yes. Ozempic starts at approximately ₹8,800 per month in India, compared to ₹13,125 per month for the starting dose of Mounjaro. However, Mounjaro produces greater weight loss for most patients.
Generic semaglutide versions are expected in India from 2026 onwards after Novo Nordisk’s patent expires. Tirzepatide (Mounjaro’s active ingredient) generics are expected around 2027–2028.
Vivo Body & Skin Clinic in Andheri West, Mumbai offers a doctor-supervised Mounjaro weight loss programme. Click here to check your eligibility and book a consultation.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any prescription medication.
Recent Posts
Mounjaro vs Ozempic: Which Weight Loss Injection Works Better in India?
Read MoreMicroneedling for Face: Side Effects, Risks and What You Should Know
Read MoreHIFU Treatment Side Effects: What You Must Know Before Choosing It
Read More
Dr. Anjali Sharma
MBBS, MD (Aesthetic Medicine)
Lead Aesthetic Physician | VivoBody & Skin Clinic, Mumbai
Dr. Anjali Sharma is a certified aesthetic and cosmetic physician with over 10 years of clinical experience in advanced skin and body treatments. As the lead expert at VivoBody & Skin Clinic, Mumbai, she specializes in non-surgical facial rejuvenation, anti-aging treatments, and body contouring procedures designed to deliver natural, long-lasting results.





